Irina A. Pikuleva - Search Results

Year	Number of Results
2002	1
2003	1
2004	3
2005	2
2006	3
2008	4
2009	4
2010	6
2011	6
2012	6
2013	8
2014	5
2015	7
2016	3
2017	5
2018	5
2019	6
2020	6
2021	6
2022	6
2023	5
2024	2

1

Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy.

Hammer SS, Dorweiler TF, McFarland D, Adu-Agyeiwaah Y, Mast N, El-Darzi N, Fortmann SD, Nooti S, Agrawal DK, Pikuleva IA, Abela GS, Grant MB, Busik JV. Hammer SS, et al. Among authors: pikuleva ia. Diabetologia. 2023 Sep;66(9):1705-1718. doi: 10.1007/s00125-023-05949-w. Epub 2023 Jun 14. Diabetologia. 2023. PMID: 37311879 Free PMC article.

2

Cholesterol-metabolizing cytochromes P450.

Pikuleva IA. Pikuleva IA. Drug Metab Dispos. 2006 Apr;34(4):513-20. doi: 10.1124/dmd.105.008789. Epub 2006 Jan 24. Drug Metab Dispos. 2006. PMID: 16434543 Review.

3

CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer's disease.

Lerner AJ, Arnold SE, Maxfield E, Koenig A, Toth ME, Fortin B, Mast N, Trombetta BA, Denker J, Pieper AA, Tatsuoka C, Raghupathy S, Pikuleva IA. Lerner AJ, et al. Among authors: pikuleva ia. Alzheimers Res Ther. 2022 Dec 29;14(1):198. doi: 10.1186/s13195-022-01151-z. Alzheimers Res Ther. 2022. PMID: 36581878 Free PMC article. Clinical Trial.

4

The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment.

Petrov AM, Mast N, Li Y, Pikuleva IA. Petrov AM, et al. Among authors: pikuleva ia. FASEB J. 2019 Aug;33(8):8782-8798. doi: 10.1096/fj.201900092R. Epub 2019 May 7. FASEB J. 2019. PMID: 31063705 Free PMC article.

5

Cytochromes p450: roles in diseases.

Pikuleva IA, Waterman MR. Pikuleva IA, et al. J Biol Chem. 2013 Jun 14;288(24):17091-8. doi: 10.1074/jbc.R112.431916. Epub 2013 Apr 30. J Biol Chem. 2013. PMID: 23632021 Free PMC article. Review.

6

Challenges and Opportunities in P450 Research on the Eye.

Pikuleva IA. Pikuleva IA. Drug Metab Dispos. 2023 Oct;51(10):1295-1307. doi: 10.1124/dmd.122.001072. Epub 2023 Mar 13. Drug Metab Dispos. 2023. PMID: 36914277 Free PMC article. Review.

7

Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases.

Petrov AM, Pikuleva IA. Petrov AM, et al. Among authors: pikuleva ia. Neurotherapeutics. 2019 Jul;16(3):635-648. doi: 10.1007/s13311-019-00731-6. Neurotherapeutics. 2019. PMID: 31001737 Free PMC article. Review.

8

Editorial: Cholesterol and Neurodegenerative Diseases - Pressing Questions and How to Address Them.

Betuing S, Pikuleva IA, Castellano JM. Betuing S, et al. Among authors: pikuleva ia. Front Aging Neurosci. 2022 Jun 8;14:948153. doi: 10.3389/fnagi.2022.948153. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35754960 Free PMC article. No abstract available.

9

Cholesterol in the retina: the best is yet to come.

Pikuleva IA, Curcio CA. Pikuleva IA, et al. Prog Retin Eye Res. 2014 Jul;41:64-89. doi: 10.1016/j.preteyeres.2014.03.002. Epub 2014 Apr 4. Prog Retin Eye Res. 2014. PMID: 24704580 Free PMC article. Review.

10

The normalizing effects of the CYP46A1 activator efavirenz on retinal sterol levels and risk factors for glaucoma in Apoj^-/- mice.

El-Darzi N, Mast N, Li Y, Dailey B, Kang M, Rhee DJ, Pikuleva IA. El-Darzi N, et al. Among authors: pikuleva ia. Cell Mol Life Sci. 2023 Jul 1;80(7):194. doi: 10.1007/s00018-023-04848-y. Cell Mol Life Sci. 2023. PMID: 37392222 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

86 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year